Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if patients older than 60, with acute myeloid
leukemia, who are in complete remission following initial chemotherapy, will live longer and
have a lower rate of leukemia relapse when treated with azacitidine.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute